Networks of excitable cells play a fundamental role in life, from the beating heart to the conscious brain.
In the time it takes to drink your coffee, experts in the field will explain how they are using Axion's technology to better understand life's circuitry.
Pour yourself a cup of coffee and learn more about life's circuitry.
Trends in cardiac safety testing, as exemplified by CiPA and JiCSA, emphasize a move beyond surrogate measures of Proarrhythmia. The hiPSC-cardiomyocyte and multiwell microelectrode array (CM-MEA) assay offers an ideal approach to evaluate proarrhythmic indicators in vitro. Join Axion BioSystems' Daniel Millard for this Coffee Break Webinar as he discusses advances in arrhythmia detection using Local Extracellular Action Potential (LEAP) technology to support next-generation CM-MEA assays.
Sixty-five million people world-wide suffer from epilepsy. Epilepsy is characterized by seizures, which are the result of excessive nerve activity in the brain. This condition is a range of disorders that vary from mild to severe, some of which can be life-threatening. While treatments are available, finding the optimal medication for any patient involves a period of trial-and-error during which both doctor and patient will try to find a solution that improves their quality of life. Unfortunately for one-third of people with epilepsy, the available treatments will not work. The need to better understand the underlying causes and develop better treatments for epilepsy are clear.
Join Columbia University's Mike Boland and K. Melodi McSweeney for this Coffee Break Webinar as they discuss the power of utilizing genetically engineered mice to explore the neuronal networks associated with epilepsy. With a better understanding of these brain networks it could be possible to classify different types of epilepsy, allowing the most effective medication to be prescribed first time.